Perceptive Advisors LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:33 pm Unchanged | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 4.900% | 0 (Unchanged) | Filing |
| 2022-02-14 5:28 pm Unchanged | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 6.300% | 0 (Unchanged) | Filing |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 6.400% | 1,296,416 (New Position) | Filing |